ArticleFrontiers in pharmacology2025

Identification of a novel dual-targeting peptide inhibitor of SARS-CoV-2 RBD and NRP1 through structure-based virtual screening.

Nan Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.